Two-year final results from STAR-I trial and initial data from STAR-II European trial tout MINIjectTM as a highly promising treatment. WAVRE, Belgium — 29 April 2020: iSTAR Medical SA, a clinical-stage medical device company pioneering truly biocompatible solutions for glaucoma, today announced positive results from two clinical trials of its micro-invasive glaucoma surgery (MIGS) implant […]
/wp-content/uploads/2016/05/Logo-Istar-CMJN-300x138.png00Katherin Awad/wp-content/uploads/2016/05/Logo-Istar-CMJN-300x138.pngKatherin Awad2020-04-29 08:00:342020-04-29 08:01:44First truly biocompatible MIGS implant from iSTAR Medical shows consistently outstanding efficacy in patients with glaucoma
To accelerate development and commercialisation of innovative Glaucoma MIGS device, MINIjectTM WAVRE, Belgium — 5 September 2019: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced the completion of a €40m Series C financing. The financing was led by healthcare specialist funds LSP and Gimv, with participation […]
/wp-content/uploads/2016/05/Logo-Istar-CMJN-300x138.png00Katherin Awad/wp-content/uploads/2016/05/Logo-Istar-CMJN-300x138.pngKatherin Awad2019-09-05 08:00:502019-09-05 02:03:50iSTAR Medical announces EUR 40m Series C Financing
WAVRE, Belgium — 10 July 2019: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced consistent 18-month results of the first-in-human, micro-invasive glaucoma surgery (MIGS) STAR-I trial for the MINIjectTM device in a standalone setting. These results confirm the stability and sustained performance of MINIject beyond the first […]
WAVRE, Belgium — 19 December 2018: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced exceptional one-year results of the first-in-human, micro-invasive glaucoma surgery (MIGS) STAR-I trial, for the MINIjectTM device in a standalone setting. Results continue to show that MINIject is safe and highly effective in […]
WAVRE, Belgium — 16 May 2018: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced exceptional six-month results of their first-in-human (FIH) micro-invasive glaucoma surgery (MIGS) trial for the MINIjectTM device in a standalone setting. Results show MINIject to be safe and highly effective in achieving significant […]
First truly biocompatible MIGS implant from iSTAR Medical shows consistently outstanding efficacy in patients with glaucoma
/in Press Releases /by Katherin AwadTwo-year final results from STAR-I trial and initial data from STAR-II European trial tout MINIjectTM as a highly promising treatment. WAVRE, Belgium — 29 April 2020: iSTAR Medical SA, a clinical-stage medical device company pioneering truly biocompatible solutions for glaucoma, today announced positive results from two clinical trials of its micro-invasive glaucoma surgery (MIGS) implant […]
iSTAR Medical announces EUR 40m Series C Financing
/in Press Releases /by Katherin AwadTo accelerate development and commercialisation of innovative Glaucoma MIGS device, MINIjectTM WAVRE, Belgium — 5 September 2019: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced the completion of a €40m Series C financing. The financing was led by healthcare specialist funds LSP and Gimv, with participation […]
iSTAR Medical’s MINIject shows consistent results at 18-month follow-up in first-in-human trial (STAR-I)
/in Press Releases /by Katherin AwadWAVRE, Belgium — 10 July 2019: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced consistent 18-month results of the first-in-human, micro-invasive glaucoma surgery (MIGS) STAR-I trial for the MINIjectTM device in a standalone setting. These results confirm the stability and sustained performance of MINIject beyond the first […]
iSTAR Medical’s MINIject maintains exceptional results in first-in-human trial one year post-surgery (STAR-I)
/in Press Releases /by Katherin AwadWAVRE, Belgium — 19 December 2018: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced exceptional one-year results of the first-in-human, micro-invasive glaucoma surgery (MIGS) STAR-I trial, for the MINIjectTM device in a standalone setting. Results continue to show that MINIject is safe and highly effective in […]
iSTAR Medical’s MINIject delivers exceptional 6-month results in first-in-human trial
/in Press Releases /by Katherin AwadWAVRE, Belgium — 16 May 2018: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced exceptional six-month results of their first-in-human (FIH) micro-invasive glaucoma surgery (MIGS) trial for the MINIjectTM device in a standalone setting. Results show MINIject to be safe and highly effective in achieving significant […]